Patient Safety – The Danish Experience. Torben Mogensen. Presentation of the National Study of Adverse Events (Madrid, Ministry of Health and Consumer Affairs, 2006)
The Canadian Adverse Events Study: The Incidence of Adverse Events among hospital patients in Canada. Philippe Hébert. Presentation of the National Study of Adverse Events(Madrid, Ministry of Health and Consumer Affairs, 2006)
The document discusses shared decision making (SDM) in clinical encounters at Mayo Clinic. It describes the work of the Knowledge and Evaluation Research (KER) Unit, which designs and evaluates decision aids to facilitate SDM between clinicians and patients. Decision aids provide unbiased information on healthcare options and help patients consider what matters most to them. Studies show decision aids improve patient knowledge and involvement without increasing consultation time. The KER Unit has created over 20 decision aids covering various medical topics. Their goal is to create meaningful conversations centered around patient needs and values to improve healthcare outcomes and experience.
Montecucco Carlo Murizio Torino 13° Convegno Patologia Immune E Malattie Orfa...cmid
This document summarizes safety data from the LORHEN registry on anti-TNF-α treatments in rheumatoid arthritis patients. It found that 18.2% of patients discontinued treatment due to adverse events, with serious infections occurring in 6.9% of patients. Risk of discontinuation due to adverse events increased with age and higher corticosteroid doses. The risk of serious infections was highest for infliximab. The study provides valuable real-world safety data on anti-TNF-α treatments from a large observational registry.
Clinical Trials in Russia Through Patients’ Eyes (ENG)Evgeny Kulikov
Results of multicenter research allowed to obtain data that describe the motivation of patients to participate in clinical trials, their expectations of participation, experience and satisfaction. We believe that the findings are of significant value to the industry of clinical trials and will make participation more comfortable for patients, and will also increase the satisfaction with participating in the study.
The document discusses new therapies and clinical trial results for treating drug-resistant epilepsy. Recent drug approvals include lacosamide and rufinamide. Drugs still in development include brivaracetam, eslicarbazepine, and retigabine. Deep brain stimulation and responsive neurostimulation devices are also being studied. Intranasal midazolam may provide a new rescue therapy option, while gamma knife radiosurgery is an alternative to open surgery for some epilepsy foci. Overall drug development is a long, expensive process requiring large clinical trials to demonstrate safety and efficacy.
A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...HMO Research Network
A simulated learning intervention using interactive virtual patient cases improved provider knowledge and confidence in managing diabetes compared to a control group. 341 resident physicians from 19 programs were randomized to an early intervention group that completed 12 virtual patient cases over 8 months or a late intervention control group. The early intervention group scored higher on a diabetes knowledge survey and reported greater confidence and knowledge in diabetes management topics compared to the control group. The results provide evidence that simulated learning can help transfer knowledge to improved care of real patients.
1) A clinical trial assessed whether chelation therapy improved quality of life outcomes in patients with stable coronary artery disease and a history of heart attack.
2) The trial found no consistent or sustained improvements in domains of health-related quality of life, including physical and mental functioning, with chelation therapy over 2 years of follow up.
3) A subgroup analysis found a potential benefit of chelation therapy for patients with angina symptoms at baseline, but no benefit was seen for patients with heart failure symptoms.
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...Cytel USA
1. The document discusses moving beyond conventional practices in translational statistics to obtain more robust and clinically meaningful results from clinical studies.
2. Several methodology issues are discussed, including how to define primary endpoints when there are multiple outcomes, how to handle dropouts and competing risks, and how to quantify treatment contrasts in a model-free way.
3. Alternative approaches are proposed for various types of studies, such as using restricted mean survival times instead of hazard ratios for survival analyses and performing meta-analyses for evaluating safety issues using large amounts of data.
The Canadian Adverse Events Study: The Incidence of Adverse Events among hospital patients in Canada. Philippe Hébert. Presentation of the National Study of Adverse Events(Madrid, Ministry of Health and Consumer Affairs, 2006)
The document discusses shared decision making (SDM) in clinical encounters at Mayo Clinic. It describes the work of the Knowledge and Evaluation Research (KER) Unit, which designs and evaluates decision aids to facilitate SDM between clinicians and patients. Decision aids provide unbiased information on healthcare options and help patients consider what matters most to them. Studies show decision aids improve patient knowledge and involvement without increasing consultation time. The KER Unit has created over 20 decision aids covering various medical topics. Their goal is to create meaningful conversations centered around patient needs and values to improve healthcare outcomes and experience.
Montecucco Carlo Murizio Torino 13° Convegno Patologia Immune E Malattie Orfa...cmid
This document summarizes safety data from the LORHEN registry on anti-TNF-α treatments in rheumatoid arthritis patients. It found that 18.2% of patients discontinued treatment due to adverse events, with serious infections occurring in 6.9% of patients. Risk of discontinuation due to adverse events increased with age and higher corticosteroid doses. The risk of serious infections was highest for infliximab. The study provides valuable real-world safety data on anti-TNF-α treatments from a large observational registry.
Clinical Trials in Russia Through Patients’ Eyes (ENG)Evgeny Kulikov
Results of multicenter research allowed to obtain data that describe the motivation of patients to participate in clinical trials, their expectations of participation, experience and satisfaction. We believe that the findings are of significant value to the industry of clinical trials and will make participation more comfortable for patients, and will also increase the satisfaction with participating in the study.
The document discusses new therapies and clinical trial results for treating drug-resistant epilepsy. Recent drug approvals include lacosamide and rufinamide. Drugs still in development include brivaracetam, eslicarbazepine, and retigabine. Deep brain stimulation and responsive neurostimulation devices are also being studied. Intranasal midazolam may provide a new rescue therapy option, while gamma knife radiosurgery is an alternative to open surgery for some epilepsy foci. Overall drug development is a long, expensive process requiring large clinical trials to demonstrate safety and efficacy.
A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...HMO Research Network
A simulated learning intervention using interactive virtual patient cases improved provider knowledge and confidence in managing diabetes compared to a control group. 341 resident physicians from 19 programs were randomized to an early intervention group that completed 12 virtual patient cases over 8 months or a late intervention control group. The early intervention group scored higher on a diabetes knowledge survey and reported greater confidence and knowledge in diabetes management topics compared to the control group. The results provide evidence that simulated learning can help transfer knowledge to improved care of real patients.
1) A clinical trial assessed whether chelation therapy improved quality of life outcomes in patients with stable coronary artery disease and a history of heart attack.
2) The trial found no consistent or sustained improvements in domains of health-related quality of life, including physical and mental functioning, with chelation therapy over 2 years of follow up.
3) A subgroup analysis found a potential benefit of chelation therapy for patients with angina symptoms at baseline, but no benefit was seen for patients with heart failure symptoms.
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...Cytel USA
1. The document discusses moving beyond conventional practices in translational statistics to obtain more robust and clinically meaningful results from clinical studies.
2. Several methodology issues are discussed, including how to define primary endpoints when there are multiple outcomes, how to handle dropouts and competing risks, and how to quantify treatment contrasts in a model-free way.
3. Alternative approaches are proposed for various types of studies, such as using restricted mean survival times instead of hazard ratios for survival analyses and performing meta-analyses for evaluating safety issues using large amounts of data.
1. The document discusses the debate around the ethics of non-inferiority and equivalence trials. Some argue they disregard patient interests in favor of commercial interests, while others believe they can be acceptable if done properly.
2. It raises several issues for discussion, including whether the concerns are truly about commercial interests, how new treatments can be evaluated when old ones must be withdrawn, and whether non-inferiority claims are valid if based on post-hoc analyses.
3. It then provides examples from clinical trials to illustrate different aspects of the debate, such as a trial where the sponsor changed the primary analysis, issues around withdrawing treatments, and considerations for determining if a new treatment is adequately proven superior or non
MET vs TAU in 4 large multisite RCTs found:
1) No main effect on retention or substance use for outpatient treatment.
2) One study found a small effect on early retention but not substance use.
3) Studies of pregnant drug users and Spanish speakers also found no main effects of MET vs TAU.
The findings suggest MET may not produce meaningful improvements over TAU in typical substance abuse treatment settings based on these high quality trials.
Ten Most Common Mistakes in Clinical Trial Interpretationclinicaltrialist
A document discusses several common cognitive optical illusions that can occur in clinical research trials. It provides examples of illusions related to regression to the mean, survivor bias, interpreting doses given to groups vs individuals, confusing proportional changes, overinterpreting p-values, making erroneous conclusions from post-hoc analyses, and incorrectly using surrogate endpoints rather than actual clinical outcomes. Researchers are encouraged to be aware of these potential illusions to avoid drawing incorrect conclusions from clinical trial data.
Ten Most Common Mistakes in Clinical Trial Interpretation - Slidecastclinicaltrialist
The document discusses two common cognitive optical illusions in clinical research: regression to the mean and survivor bias. Regression to the mean occurs when subgroups appear to benefit more from treatment due to natural fluctuations in disease severity over time. Survivor bias happens when a treatment appears harmful by the primary endpoint but beneficial when considering combined endpoints. The document provides examples and explanations of how these illusions can influence clinical trial results.
Medical Decision Making associated with Clinical test interpretations. Depending on the situation one should get a second test to confirm the result of the first one; or one should move on to the treatment phase.
This document summarizes a review study comparing treatment results for prostate cancer. Over 21,000 prostate studies published between 2000-2011 were reviewed, with 145 meeting criteria for inclusion. Experts from various treatment disciplines (e.g. surgery, radiation) assembled to conduct a complete literature review on prostate cancer treatment success rates based on PSA levels. Results are presented separating patients into low, intermediate, and high risk groups.
This document discusses cardiovascular risk and adherence to treatment. It defines key terms like adherence, compliance, persistence, and non-adherence. It notes that poor adherence is a major reason for suboptimal clinical benefits. It also discusses factors that influence adherence like the medication, patient, and healthcare system. Non-adherence can increase risks of stroke, death, hospitalizations and costs. Long-term adherence to medications for conditions like hypertension and statins is often low, around 50%. Improving adherence requires addressing multiple barriers and ensuring patients are involved in treatment decisions.
This document summarizes data from 136 palliative care patients seen by the Palliative Care Quality Network between November 8-9, 2012. Key findings include:
- The average age of patients was 74 years old and over half were female. Most referrals came from medical/surgical units and were for symptom management, pain management, or advance care planning.
- Cancer was the most common primary diagnosis. Documentation of goals of care and code status varied between hospitals. Multidisciplinary teams including nurses, doctors, and social workers provided consultations.
- Pain, anxiety, and dyspnea were the most common initial symptoms. Symptoms improved for most patients within 24 hours of the palliative care consultation
The document summarizes research into how users associate diseases with medical categories and findings from usability testing of a diseases and conditions section of a healthcare website. Key findings include that for several diseases, such as cyclic vomiting syndrome, head lice, and insomnia in children, users associated them with different categories than clinical definitions. The research recommends providing category definitions and expanding categories based on user feedback to improve findability for diseases by 88% of users.
This document summarizes guidelines for non-occupational post-exposure prophylaxis (nPEP) for HIV. It recommends that nPEP be offered for exposures over 72 hours prior only if the source patient is known to be HIV positive or of unknown status. For exposures within 72 hours, nPEP is recommended if the source patient is HIV positive or of unknown status. The decision to offer nPEP should be made on a case-by-case basis. The document also discusses factors that influence decisions to start nPEP and reasons some may not start it after exposure. It concludes by providing contact information for the presenting author.
David Wennberg, MD, MPH, describes a recent randomized trial he was involved with that studied the potential of shared decision making to reduce costs among preference-sensitive conditions. David also explains the vision of the 20-member High Value Healthcare Collaborative.
This presentation was part of the Shared Decision Making Month webinar "Turning Shared Decision Making Policy into a Reality."
ACE: The First Experience with Angiographic Reviewsbnolke
This document summarizes the findings from the first 10 facilities reviewed by the Accreditation for Cardiovascular Excellence (ACE) program. It found that while the majority of cases met quality standards, documentation was often inadequate, incomplete, or inconsistent. Indications for procedures and results of in-lab testing were not always clearly documented. Random case reviews, an important part of quality assurance, were not routinely performed at most facilities. The conclusions call for improved documentation in cath reports and increased use of random case reviews.
The document provides information on several topics related to dermatology. It discusses personalized therapy for some cancers like melanoma that will use genetic and molecular biomarkers to select patients for targeted therapies including immunotherapy. It also discusses painless photodynamic therapy for actinic keratoses that reduces treatment time from 14-18 hours to only 90 minutes with less pain reported by patients. Finally, it summarizes the results of two clinical trials showing that the drug Otezla was effective for treating moderate to severe plaque psoriasis, with 33% of patients achieving a 75% improvement in symptoms compared to only 5% on placebo.
Pan Pacific Clinical Practice Guideline For The Prevention And Management Of ...GNEAUPP.
This document provides a summary of the Pan Pacific Clinical Practice Guideline for the Prevention and Management of Pressure Injuries, which was published in 2012. The guideline was developed through an extensive review process and in collaboration with experts from Australia, New Zealand, Hong Kong, and Singapore. It aims to optimize the prevention, assessment, and treatment of pressure injuries across the healthcare systems of these regions. The guideline provides evidence-based recommendations on topics such as risk assessment, prevention, wound assessment and classification, interventions, and organizational considerations.
Comparisonof Clinical Diagnoses versus Computerized Test Diagnoses Using the ...Nelson Hendler
The Diagnostic Paradigm from www.MarylandClinicalDiagnostics.com was able to help the former Dean of Los Angeles Chiropractic College detect medical diagnoses which he had overlooked, and he later confirmed.
This document discusses principles of radiation therapy and dose selection for various conditions. It provides guidelines for selecting marginal doses for different tumor types based on location and size, including doses of 12-13 Gy for acoustic neuromas, 16-25 Gy for pituitary adenomas, 12-15 Gy for benign meningiomas, and 20-24 Gy for arteriovenous malformations. Risk models are presented for complications after radiosurgery for brain metastases and arteriovenous malformations based on tumor location and volume. Guidelines aim to maximize tumor control while minimizing risks of complications like necrosis and cranial neuropathy.
Bariatric surgery and copra ossicon 2016 presentationAbhishek Katakwar
The document discusses issues related to medical negligence and litigation faced by bariatric surgeons, highlighting several court cases where doctors were found guilty of negligence. It provides an overview of the key factors that contribute to negligence claims, such as lack of informed consent, non-adherence to protocols, and inadequate patient education. The document also offers guidance to bariatric surgeons on minimizing litigation risks and ensuring best practices for patient selection, evaluation, counseling and follow-up.
This document defines key terms used in evidence-based medicine including those related to validity, therapy, diagnosis, bias and statistics. It provides definitions for internal and external validity, randomization, concealment, blindness, intention-to-treat analysis, sensitivity, specificity, likelihood ratios, absolute risk reduction, relative risk reduction, number needed to treat, confidence intervals, and biases such as detection and publication bias. An example is also given to calculate and interpret results including relative risk, absolute risk reduction, relative risk reduction and number needed to treat from a randomized controlled trial.
Eliminate devastating medical errors with 10 high reliability safety toolsJohn Byrnes, MD
This document outlines 10 proven high reliability tools that can be used in healthcare to reduce medical errors and improve patient safety. It begins with an introduction by the presenters, Dr. John Byrnes and Sonja Beute, who have extensive experience in healthcare quality and safety. The document then discusses how medical errors are a leading cause of death in the US and how adopting high reliability principles from industries like aviation can help reduce errors. It proceeds to describe 10 specific high reliability tools used in aviation that can be applied to healthcare, including checklists, crew resource management, briefings, standardized processes, and engineering solutions like mistake proofing.
Patient Satisfaction, Patient Reported Outcomes, Safety, and Quality of CareYana Puckett, MD, MPH, MS
This document discusses patient safety and medical errors. It notes that while human error is inevitable in healthcare, medical errors result in significant deaths and costs each year. To improve patient safety, the document advocates evaluating health systems, promoting a culture of reporting errors without blame, learning from mistakes, and designing systems to prevent errors and mitigate their effects if they do occur. The use of electronic health records and other technologies can help monitor patients and avoid some errors, but overreliance on computers also risks new types of mistakes, so limitations must be considered. Overall patient safety is improved when healthcare systems focus on evaluation, open communication, and making changes based on lessons learned over time.
CU Errors, clinical governance and patient safetyMedic-ELearning
The document provides an overview of clinical governance, patient safety, and error prevention. It defines key terms like errors, incidents, and near-misses. It describes the National Patient Safety Agency's role in collecting incident reports to identify risks and improve safety. The document also discusses how most incidents are due to failures in systems and processes rather than individuals, and how a culture of learning from incidents can help prevent future harm.
1. The document discusses the debate around the ethics of non-inferiority and equivalence trials. Some argue they disregard patient interests in favor of commercial interests, while others believe they can be acceptable if done properly.
2. It raises several issues for discussion, including whether the concerns are truly about commercial interests, how new treatments can be evaluated when old ones must be withdrawn, and whether non-inferiority claims are valid if based on post-hoc analyses.
3. It then provides examples from clinical trials to illustrate different aspects of the debate, such as a trial where the sponsor changed the primary analysis, issues around withdrawing treatments, and considerations for determining if a new treatment is adequately proven superior or non
MET vs TAU in 4 large multisite RCTs found:
1) No main effect on retention or substance use for outpatient treatment.
2) One study found a small effect on early retention but not substance use.
3) Studies of pregnant drug users and Spanish speakers also found no main effects of MET vs TAU.
The findings suggest MET may not produce meaningful improvements over TAU in typical substance abuse treatment settings based on these high quality trials.
Ten Most Common Mistakes in Clinical Trial Interpretationclinicaltrialist
A document discusses several common cognitive optical illusions that can occur in clinical research trials. It provides examples of illusions related to regression to the mean, survivor bias, interpreting doses given to groups vs individuals, confusing proportional changes, overinterpreting p-values, making erroneous conclusions from post-hoc analyses, and incorrectly using surrogate endpoints rather than actual clinical outcomes. Researchers are encouraged to be aware of these potential illusions to avoid drawing incorrect conclusions from clinical trial data.
Ten Most Common Mistakes in Clinical Trial Interpretation - Slidecastclinicaltrialist
The document discusses two common cognitive optical illusions in clinical research: regression to the mean and survivor bias. Regression to the mean occurs when subgroups appear to benefit more from treatment due to natural fluctuations in disease severity over time. Survivor bias happens when a treatment appears harmful by the primary endpoint but beneficial when considering combined endpoints. The document provides examples and explanations of how these illusions can influence clinical trial results.
Medical Decision Making associated with Clinical test interpretations. Depending on the situation one should get a second test to confirm the result of the first one; or one should move on to the treatment phase.
This document summarizes a review study comparing treatment results for prostate cancer. Over 21,000 prostate studies published between 2000-2011 were reviewed, with 145 meeting criteria for inclusion. Experts from various treatment disciplines (e.g. surgery, radiation) assembled to conduct a complete literature review on prostate cancer treatment success rates based on PSA levels. Results are presented separating patients into low, intermediate, and high risk groups.
This document discusses cardiovascular risk and adherence to treatment. It defines key terms like adherence, compliance, persistence, and non-adherence. It notes that poor adherence is a major reason for suboptimal clinical benefits. It also discusses factors that influence adherence like the medication, patient, and healthcare system. Non-adherence can increase risks of stroke, death, hospitalizations and costs. Long-term adherence to medications for conditions like hypertension and statins is often low, around 50%. Improving adherence requires addressing multiple barriers and ensuring patients are involved in treatment decisions.
This document summarizes data from 136 palliative care patients seen by the Palliative Care Quality Network between November 8-9, 2012. Key findings include:
- The average age of patients was 74 years old and over half were female. Most referrals came from medical/surgical units and were for symptom management, pain management, or advance care planning.
- Cancer was the most common primary diagnosis. Documentation of goals of care and code status varied between hospitals. Multidisciplinary teams including nurses, doctors, and social workers provided consultations.
- Pain, anxiety, and dyspnea were the most common initial symptoms. Symptoms improved for most patients within 24 hours of the palliative care consultation
The document summarizes research into how users associate diseases with medical categories and findings from usability testing of a diseases and conditions section of a healthcare website. Key findings include that for several diseases, such as cyclic vomiting syndrome, head lice, and insomnia in children, users associated them with different categories than clinical definitions. The research recommends providing category definitions and expanding categories based on user feedback to improve findability for diseases by 88% of users.
This document summarizes guidelines for non-occupational post-exposure prophylaxis (nPEP) for HIV. It recommends that nPEP be offered for exposures over 72 hours prior only if the source patient is known to be HIV positive or of unknown status. For exposures within 72 hours, nPEP is recommended if the source patient is HIV positive or of unknown status. The decision to offer nPEP should be made on a case-by-case basis. The document also discusses factors that influence decisions to start nPEP and reasons some may not start it after exposure. It concludes by providing contact information for the presenting author.
David Wennberg, MD, MPH, describes a recent randomized trial he was involved with that studied the potential of shared decision making to reduce costs among preference-sensitive conditions. David also explains the vision of the 20-member High Value Healthcare Collaborative.
This presentation was part of the Shared Decision Making Month webinar "Turning Shared Decision Making Policy into a Reality."
ACE: The First Experience with Angiographic Reviewsbnolke
This document summarizes the findings from the first 10 facilities reviewed by the Accreditation for Cardiovascular Excellence (ACE) program. It found that while the majority of cases met quality standards, documentation was often inadequate, incomplete, or inconsistent. Indications for procedures and results of in-lab testing were not always clearly documented. Random case reviews, an important part of quality assurance, were not routinely performed at most facilities. The conclusions call for improved documentation in cath reports and increased use of random case reviews.
The document provides information on several topics related to dermatology. It discusses personalized therapy for some cancers like melanoma that will use genetic and molecular biomarkers to select patients for targeted therapies including immunotherapy. It also discusses painless photodynamic therapy for actinic keratoses that reduces treatment time from 14-18 hours to only 90 minutes with less pain reported by patients. Finally, it summarizes the results of two clinical trials showing that the drug Otezla was effective for treating moderate to severe plaque psoriasis, with 33% of patients achieving a 75% improvement in symptoms compared to only 5% on placebo.
Pan Pacific Clinical Practice Guideline For The Prevention And Management Of ...GNEAUPP.
This document provides a summary of the Pan Pacific Clinical Practice Guideline for the Prevention and Management of Pressure Injuries, which was published in 2012. The guideline was developed through an extensive review process and in collaboration with experts from Australia, New Zealand, Hong Kong, and Singapore. It aims to optimize the prevention, assessment, and treatment of pressure injuries across the healthcare systems of these regions. The guideline provides evidence-based recommendations on topics such as risk assessment, prevention, wound assessment and classification, interventions, and organizational considerations.
Comparisonof Clinical Diagnoses versus Computerized Test Diagnoses Using the ...Nelson Hendler
The Diagnostic Paradigm from www.MarylandClinicalDiagnostics.com was able to help the former Dean of Los Angeles Chiropractic College detect medical diagnoses which he had overlooked, and he later confirmed.
This document discusses principles of radiation therapy and dose selection for various conditions. It provides guidelines for selecting marginal doses for different tumor types based on location and size, including doses of 12-13 Gy for acoustic neuromas, 16-25 Gy for pituitary adenomas, 12-15 Gy for benign meningiomas, and 20-24 Gy for arteriovenous malformations. Risk models are presented for complications after radiosurgery for brain metastases and arteriovenous malformations based on tumor location and volume. Guidelines aim to maximize tumor control while minimizing risks of complications like necrosis and cranial neuropathy.
Bariatric surgery and copra ossicon 2016 presentationAbhishek Katakwar
The document discusses issues related to medical negligence and litigation faced by bariatric surgeons, highlighting several court cases where doctors were found guilty of negligence. It provides an overview of the key factors that contribute to negligence claims, such as lack of informed consent, non-adherence to protocols, and inadequate patient education. The document also offers guidance to bariatric surgeons on minimizing litigation risks and ensuring best practices for patient selection, evaluation, counseling and follow-up.
This document defines key terms used in evidence-based medicine including those related to validity, therapy, diagnosis, bias and statistics. It provides definitions for internal and external validity, randomization, concealment, blindness, intention-to-treat analysis, sensitivity, specificity, likelihood ratios, absolute risk reduction, relative risk reduction, number needed to treat, confidence intervals, and biases such as detection and publication bias. An example is also given to calculate and interpret results including relative risk, absolute risk reduction, relative risk reduction and number needed to treat from a randomized controlled trial.
Eliminate devastating medical errors with 10 high reliability safety toolsJohn Byrnes, MD
This document outlines 10 proven high reliability tools that can be used in healthcare to reduce medical errors and improve patient safety. It begins with an introduction by the presenters, Dr. John Byrnes and Sonja Beute, who have extensive experience in healthcare quality and safety. The document then discusses how medical errors are a leading cause of death in the US and how adopting high reliability principles from industries like aviation can help reduce errors. It proceeds to describe 10 specific high reliability tools used in aviation that can be applied to healthcare, including checklists, crew resource management, briefings, standardized processes, and engineering solutions like mistake proofing.
Patient Satisfaction, Patient Reported Outcomes, Safety, and Quality of CareYana Puckett, MD, MPH, MS
This document discusses patient safety and medical errors. It notes that while human error is inevitable in healthcare, medical errors result in significant deaths and costs each year. To improve patient safety, the document advocates evaluating health systems, promoting a culture of reporting errors without blame, learning from mistakes, and designing systems to prevent errors and mitigate their effects if they do occur. The use of electronic health records and other technologies can help monitor patients and avoid some errors, but overreliance on computers also risks new types of mistakes, so limitations must be considered. Overall patient safety is improved when healthcare systems focus on evaluation, open communication, and making changes based on lessons learned over time.
CU Errors, clinical governance and patient safetyMedic-ELearning
The document provides an overview of clinical governance, patient safety, and error prevention. It defines key terms like errors, incidents, and near-misses. It describes the National Patient Safety Agency's role in collecting incident reports to identify risks and improve safety. The document also discusses how most incidents are due to failures in systems and processes rather than individuals, and how a culture of learning from incidents can help prevent future harm.
1. The document discusses TeamSTEPPS, a training initiative to improve teamwork and communication in healthcare to enhance patient safety and outcomes.
2. TeamSTEPPS provides a framework and curriculum to teach core teamwork competencies including leadership, situation monitoring, mutual support and communication.
3. Research has shown that adopting a TeamSTEPPS approach and strengthening teamwork can reduce medical errors and preventable deaths, though widespread changes have been slow to be implemented across the healthcare system.
Reducing Medical Error and increasing patient safety Reducing Medical Error...MedicineAndHealth
Medical errors are common and result in many deaths each year. Around half of adverse events in hospitals are preventable. Errors often occur due to systemic issues rather than individual negligence. To improve patient safety, healthcare systems must be designed with a focus on safety, adopting principles such as encouraging reporting of errors without punishment, and continual learning and improvement from past errors and near misses.
This document discusses medical errors and increasing patient safety. It summarizes several studies that found medical errors are common, with rates of adverse events from around 3-17% of hospital admissions. Errors result in tens of thousands of unnecessary deaths annually. Most errors are due to cognitive mistakes and "system" failures rather than individual negligence. To improve safety, the document argues we must think of errors as systems failures and implement strategies like checklists, standardized procedures, training, and a culture where safety is a top priority and errors are reported to fix underlying issues rather than blame individuals.
Krish Sankaranarayanan has over 24 years of experience in healthcare and holds multiple degrees including an MS in Patient Safety Leadership. He discussed the historical context of patient safety including figures like Florence Nightingale and Dr. Codman who helped establish standards. High reliability organizations have zero tolerance for errors, unlike healthcare which has error rates comparable to less safe industries. Common causes of medical errors include miscommunication and lack of standardized processes. The presentation provided tools and techniques to improve safety including accreditation, checklists, and focusing on system design rather than individual blame.
In the presentation, a summary of initiatives to be taken by hospitals in different areas for patient safety have been described for the knowledge, practices and implementation of patient safety initiative by hospital managers/Administrators.
This document discusses statistical issues related to using patient-reported outcome (PRO) measures in clinical trials. It notes that PROs are often measured on an ordinal scale with skewed distributions and are subject to floor and ceiling effects. Standard analysis methods may not be appropriate. It also discusses challenges like regression to the mean, baseline adjustment, and evaluating change over time without a control group. While a multi-scale PRO like a health-related quality of life instrument can be used as a primary endpoint, its multidimensional nature raises issues around validation and methodology compared to single measures. Regulatory agencies provide guidance on properly using PROs, including multi-scale ones, as primary endpoints.
Parallel Session 4.6 Developing Your Team’s Safety Culture and Safety Practic...NHSScotlandEvent
The document discusses improving safety culture and practices in primary care through implementing a patient safety program. It outlines why safety is important in primary care given the high volume of patients and risk of harm from errors. The program aims to help primary care teams identify and reduce harm through tools like reliable care bundles, trigger tools to detect harm, and surveys to measure safety climate and culture.
This document summarizes key findings from a study on returning genomic sequencing results to patients with idiopathic diseases and their physicians. The study found that [1] physicians may need help interpreting and communicating genomic results to patients, as post-sequencing patients graded their physician's communication skills lower than pre-sequencing, and [2] both patients and physicians preferred that secondary or incidental findings from sequencing be returned. The study highlights the challenges of integrating genomic medicine into clinical practice and the need for improved physician education in genetics and result disclosure.
Risk Management and Patient Safety Evolution and Progress. Charles Vincent. Match Safety critical component of quality (Madrid, Ministry of Health and Consumer Affairs, 2005)
Apply Patient Safety Solutions to Clinical Practice: why is it so hard by S. ...ALIAS Network
The document summarizes a presentation given by Sara Albolino and Riccardo Tartaglia on applying patient safety solutions in clinical practice. The presentation covered:
1) Barriers to improving patient safety in healthcare, including differences from other high-risk industries and emotional involvement of clinicians.
2) Studies showing the incidence of adverse events is around 9% globally but improving slowly despite efforts.
3) Interventions need to consider the healthcare context and developing a safety culture is important to improving reliability.
4) A systems approach is necessary to address patient safety, not just individual practices or technologies. Standardization and measuring outcomes is important going forward.
The document discusses medical errors and their relationship to negligence and malpractice litigation. Some key points:
- Medical errors are estimated to cause between 44,000-98,000 deaths per year in the US, making it a leading cause of death. However, other studies estimate a lower number of around 5,000 deaths due to errors.
- Only a small percentage (around 1-2%) of medical errors result in negligent injuries. Of those negligent injuries, only 10-13% result in malpractice claims.
- Common reasons for malpractice litigation include needing money, believing there was a cover up, or wanting information or revenge. However, the system rarely identifies or holds providers accountable for substandard care
This document discusses antidepressant use in the Netherlands. It finds that while 900,000 patients are treated for depression each year, only 14% of patients meet eligibility criteria for clinical trials of antidepressants. Many patients do not continue antidepressant treatment as recommended by guidelines. Approximately 30% of patients stop treatment abruptly, experiencing discontinuation side effects, while others create homemade tapering schedules or use schedules from their doctor. The document examines patterns of initiation, adherence, and discontinuation of antidepressant treatment using pharmacy records data.
Samir Sinha: Canadian innovation in caring for older adultsNuffield Trust
This document provides an overview of innovations in caring for older adults across the continuum of care in Canada. It introduces the Acute Care for Elders (ACE) strategy, an integrated care model shown to deliver better outcomes for patients and the healthcare system. The document describes how Mount Sinai Hospital in Toronto implemented an ACE strategy through interprofessional teams and programs across inpatient, outpatient and home-based settings. Evaluations show the ACE strategy at Mount Sinai reduced length of stay, increased rates of patients returning home, and improved patient satisfaction and staff experience with geriatrics care.
The document discusses the evidence base for digital healthcare technologies. It provides a table outlining the types of studies needed to evaluate digital health technologies. The document then examines several case studies, summarizing the evidence around technologies like decision support systems, telehealth, and serious games. It finds some evidence of benefits but also notes limitations and failures of some studies. The document emphasizes that the impact of technologies depends on context and more rigorous evaluation is still needed.
The document discusses the evidence base for digital healthcare technologies. It provides a table outlining the types of studies needed to evaluate digital health technologies. The document then examines several case studies, summarizing the evidence around technologies like decision support systems, telehealth, and serious games. It finds some evidence of benefits but also notes limitations and failures of some studies. The conclusion calls for more rigorous evaluation studies that consider clinical and cost effectiveness in real-world contexts.
This document discusses screening and diagnostic tests. It defines screening and diagnostic tests as tools used to distinguish people who have a disease from those who do not. The quality and accuracy of these tests is important to understand. Tests are evaluated based on their sensitivity, specificity, predictive values, and likelihood ratios compared to a gold standard. Factors like disease prevalence can impact predictive values. Receiver operating characteristic curves are used to evaluate test performance across all thresholds. Screening tests aim to identify disease early but must account for biases and show effectiveness of interventions.
The document discusses age, comorbidity, and frailty in elderly patients. It introduces tools like the Preoperative Assessment of Cancer in the Elderly (PACE) and the Groningen Frailty Index (GFI) that are used to assess frailty in elderly surgical patients. The PACE evaluates factors like cognition, activities of daily living, mood, and fatigue. Research found certain components of the PACE like dependency in activities of daily living were associated with increased hospital stay and complications. The GFI contains 15 questions assessing domains like mobility, nutrition, and cognition. A GFI score of 3 or higher indicates frailty. The tools aim to identify frailty preoperatively to predict outcomes and prevent functional decline.
Efficacy and safety of microvascular decompression for trigeminal in patients...neurologia segura
This study evaluated the efficacy and safety of microvascular decompression (MVD) for treating trigeminal neuralgia in patients with morbid obesity. The study found that while MVD surgery took longer and had higher risks in obese patients, it was still effective at reducing pain. Specifically, obese patients had longer surgery/anesthesia times, more pre-existing health issues, and higher complication rates during intubation. However, obese patients still experienced significant pain relief following surgery similar to non-obese patients, with over 65% reporting an excellent outcome. The study concluded that MVD should be considered for obese patients with TN when it is the only effective treatment option, and can be performed safely in specialized medical centers.
This document provides an overview of patient safety initiatives and issues in hospitals. It discusses that 10% of hospital patients suffer adverse events, with medical errors causing around 100,000 deaths per year in the US. Common types of errors include overdoses and performing procedures on the wrong patient. The document then outlines the Patient Safety Friendly Hospital Initiative, which develops standards to assess patient safety in hospitals and has piloted the approach in 7 countries. It describes the five domains used to measure hospital performance on patient safety and provides examples of critical and core standards. The document concludes by offering recommendations on how hospitals can develop their own patient safety programs.
Screening tests aim to identify unrecognized disease in asymptomatic individuals. An effective screening program requires a suitable disease, test, and screening process. A suitable disease is serious, progressive, treatable at an early stage, and has a detectable pre-clinical phase. An effective screening test is inexpensive, easy to administer, valid, reliable, and has acceptable sensitivity and specificity. Screening programs must consider disease prevalence, test validity, reliability, and yield to determine if screening provides benefit.
Current Scenario in Male Infertility for IVF SpecialistsSandro Esteves
This document summarizes a lecture given by Dr. Sandro Esteves on male infertility. Some key points:
1) Evidence shows that antioxidant supplements like vitamins C and E can help improve semen parameters and fertility outcomes for men with infertility. They work to reduce oxidative stress on sperm cells.
2) New WHO standards for semen analysis from 2010 lowered the reference values, which may incorrectly classify some previously abnormal results as normal. However, they provide a standardized assessment approach.
3) Beyond routine semen analysis, tests of sperm DNA integrity and screening for Y chromosome microdeletions can provide additional diagnostic information for infertility evaluation and treatment planning.
IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011Sano y Salvo
Es la conferencia inaugural de la IV Jornada, de Borrell-Carrió. Hizo una revisión muy interesante de como nuestros automatismos mentales pueden poner en riesgo la práctica de un diagnóstico acertado, sobretodo en los casos en los que la primera impresión no es la acertada.
Case-control and cohort studies are two main types of epidemiological study designs. [1] Case-control studies determine the distribution of disease and examine determinants of disease by comparing exposures in individuals who have the disease (cases) to individuals who do not have the disease (controls). [2] Cohort studies follow groups of individuals who are free of disease and examine how many develop the disease over time based on exposures. [3] Both study designs aim to judge whether a given exposure causes or prevents disease.
This study evaluated the incidence and consequences of misdiagnosed twin-twin transfusion syndrome (TTTS). The researchers found that in 33.1% of TTTS cases treated with laser surgery, the chorionicity was incorrectly identified or TTTS was misdiagnosed prior to referral. Cases of misdiagnosed TTTS were referred later in pregnancy at a more advanced stage of disease. This resulted in worse maternal and neonatal outcomes including higher rates of preterm birth and neonatal death. The study emphasizes the importance of accurate identification of chorionicity in early pregnancy scans and close monitoring of monochorionic twin pregnancies to enable early diagnosis and treatment of TTTS.
Similar to Patient Safety – The Danish Experience (20)
Multidisciplinary care: a perspective from diagnosis and treatment of rare cancers. Casali P. Technical Conference: Multidisciplinary Care in Cancer as a model of health care quality (Madrid: Ministry of Health and Social Policy, 2010)
La mejor evidencia junto a la mejor organización: el reto de la coordinación profesional en atención oncológica. Sánchez de Toledo J. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
La mejor evidencia junto a la mejor organización: el reto de la coordinación profesional en atención oncológica. Ortiz H. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
La mejor evidencia junto a la mejor organización: el reto de la coordinación profesional en atención oncológica. Barnadas A. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
Experiencias y percepción de la atención integral de los pacientes con cáncer. Oriol Díaz de Bustamante I. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
Experiencias y percepción de la atención integral de los pacientes con cáncer. Moreno Marín P. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
La mejor evidencia junto a la mejor organización: el reto de la coordinación profesional en atención oncológica. Medina JA. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
Experiencias y percepción de la atención integral de los pacientes con cáncer. Fisas Armengol A. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
Este documento describe la atención oncológica multidisciplinar y la gestión de casos como un modelo de calidad asistencial. Explica que la gestión de casos implica coordinar y facilitar el acceso a los servicios sanitarios adecuados para cada paciente. Además, describe el rol de la enfermera gestora de casos en unidades oncológicas, cuyas funciones principales son coordinar el plan de tratamiento del paciente y servir de referente para el paciente y el equipo médico. Finalmente, concluye que la gestión de casos contribuye
La mejor evidencia junto a la mejor organización: el reto de la coordinación profesional en atención oncológica. Díaz Mediavilla J. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
La mejor evidencia junto a la mejor organización: el reto de la coordinación profesional en atención oncológica. Ignacio A. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
The power of lifestyle interventions to prevent cardiovascular diseases. Tuomilehto J. Conference on Cardiovascular Diseases (Madrid: Ministry of Health and Social Policy; 2010).
Alcohol and chronic diseases: complex relations. Guillemont J. Conference on Cardiovascular Diseases (Madrid: Ministry of Health and Social Policy; 2010).
Risk Assessment and Management of Cardiovascular Diseases - an English Approach. Lynam E. Conference on Cardiovascular Diseases (Madrid: Ministry of Health and Social Policy; 2010).
Cardiovascular disease inequalities: causes and consequences. Capewell S. Conference on Cardiovascular Diseases (Madrid: Ministry of Health and Social Policy; 2010).
Addressing cardiovascular disease at EU level: tangible plans for the future. Hübel M. Conference on Cardiovascular Diseases (Madrid: Ministry of Health and Social Policy; 2010).
1) Denmark aimed to create common processes and data structures across 13 municipalities and multiple medical vendors from 2002-2007, but faced issues with too many concurrent users and high data transmission.
2) From 2007-2012, Denmark established a shared medication record and common database to address prior issues.
3) The document discusses various roles that medical intermediaries can play, including consumer/professional content aggregation, patient management, records management, physician career services, and more. It also covers intermediation theory and the challenges in Europe.
The impact of eHealth on Healthcare Professionals and Organisations: The Impact of ICT at Kaiser Permanente. Wiesenthal A. eHealth week 2010 (Barcelona: CCIB Convention Centre; 2010)
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
1. Patient Safety – The Danish Experience
Torben Mogensen, Medical Director
Hvidovre Hospital, Denmark
2.
3. Aim of the preliminary
study
Calculation for full scale investigation
Test of method
Question:
The number of adverse events in Denmark =
number of adverse events in other countries ?
Estimation of the cost of adverse events
Estimation of the potential for prevention
4. Expected results of the
preliminary investigation
÷
+
Number of adverse
Number of adverse
events at each hospital
events in Denmark
or department
The price for adverse
Disability
events
Number of death
Potential for prevention
Which speciality
Test of method
Causation
Calculation for full
scale investigation Identification of
patients with risk
Comparison of hospital
5. 1.1
inp 07.6 Adverse Events Studies
ati 32
en
ts
England Harvard Australia Utah/Colorado
10,8 %
Number of AEs 40.982
3,7 % 143.992
13,0 % 32.121
2,9 %
AE’s 119.624
66 % AEs
Mild 56,8 % 46,6 % 53,3 %
Mild
19 %
Modera. Moderate AEs 13,7 % 30,5 % 31,6 %
6%
Severe AEs 2,6 % 13,7 % 8,4 %
Severe
Deaths 8% Deaths 13,6 %
5.574 4,9 %
7.056 6,6 %
2.120
9.787
7. Definitions
Adverse event
Not preventable Ae Preventable Ae
(complication) (error)
Technical error Human error
Latent failures Active error
Error of
Error of action
omission
8. Latent and active error
-Human factor analyses
Stanhope et al: Br J Obst and Gyne ,
nov 97, 104, 1225 -1232
11. Method In-patients
Representative sample
1. step
Nurse screening
Positive screening
Medical evaluation Medical evaluation
2. step
Comparison of answers
Possible adverse event
3. step
Senior medical evaluation Senior medical evaluation
Conference
12. 1.107.632
In-patients
Results
1.097
Representative sample
Record not useful Nurse screening 1033
622 411
Negative screening Positive screening
Medical evaluation Medical evaluation
Comparison of answers
No adverse event Adverse event
Possible adverse event
64
Senior medical evaluation Senior medical evaluation
282
Conference
No adverse event Adverse event
No conclusion
904 15 114
13. Results
• 176 adverse events (complications & error)
• 114 admissions with adverse events
• 46 preventive adverse events (error)
• Risk of adverse events and complications 5,3 % (54/1018)
• Risk of adverse events due to error 2,1 %(22/1018)
• Number of admissions with adverse events 9,0 %(92/1018)
• Number of admissions with adverse events
due to error 3,6 %(37/1018)
• Increase in length of stay due to adverse events 7,0 days
15. Preliminary investigation of adverse events
2001
No adverse events 91%
”Error” 40%
Standard treatment 60%
Adverse events 9%
www.dsi.dk/publikationer
16. 1 .1
pa 07.63 Adverse Events Studies
tie
nte 2
r
Denmark
Harvard Australia Utah/Colorado
1998
Number
3,7 % 13,0 % 2,9 %
40.982 143.992 32.121 115.104
of AEs
46,6 % 53,3 %
56,8 %
Mild AEs
Moderate
30,5 % 31,6 %
13,7 %
AEs
13,7 % 8,4 %
2,6 %
Severe AEs
4,9 % 6,6 % 7.067
13,6 %
5.574 7.056 2.120
Deaths
17. Conclusions
• The total amount of adverse events in Denmark
are comparable with previous studies from other
countries.
- Not better – not worse -
• The number of preventable adverse events are
the same as in previous studies.
• The investigation too small to evaluate the
number of death due to adverse events.
18. The Magic 3 Years
Danish Society for
Patient Safety
Law on Patient
Danish A.E.
Safety
Study
published
H:S Unit of
Study with
Patient Safety
Recommendations
What is Patient
Safety?
2000 2001 2002 2003
19. Teamwork
Danish Society for Patient Safety
• Established December, 2001
• Stakeholders represented in the board by their
president (hospital owners, professions, industry,
research & patient organisations)
• Gathers, spreads and develops knowledge and
initiatives
• Has become an important political factor
20. Law on Patient Safety
Law on Patient Safety
passed in the
ion
Parliament June 2003
sat
Learning
t
lain
en
mp
mp
Co
Co
21. Law on Patient Safety,
June 2003
Frontline Personnel obligated to report
Hospital Owners are obligated to act
Board of Health are obligated to
communicate
22. §6 in Law on
Patient Safety
A health care professional reporting an
adverse event shall not as a result of such
reporting be subjected to disciplinary
investigations or measures by the
Employing Authority, Supervisory
Reactions by the National Board of Health
or Criminal Sanctions by the Courts.